Ipca Laboratories Limited

NSEI:IPCALAB 株式レポート

時価総額:₹403.7b

Ipca Laboratories マネジメント

マネジメント 基準チェック /14

現在、CEO に関する十分な情報がありません。

主要情報

Pranay Godha

最高経営責任者

₹65.2m

報酬総額

CEO給与比率25.7%
CEO在任期間1.6yrs
CEOの所有権0.7%
経営陣の平均在職期間データなし
取締役会の平均在任期間9.5yrs

経営陣の近況

Recent updates

Ipca Laboratories (NSE:IPCALAB) Is Paying Out A Dividend Of ₹2.00

Nov 17
Ipca Laboratories (NSE:IPCALAB) Is Paying Out A Dividend Of ₹2.00

Earnings Tell The Story For Ipca Laboratories Limited (NSE:IPCALAB)

Sep 10
Earnings Tell The Story For Ipca Laboratories Limited (NSE:IPCALAB)

Ipca Laboratories' (NSE:IPCALAB) Solid Earnings Have Been Accounted For Conservatively

Jun 07
Ipca Laboratories' (NSE:IPCALAB) Solid Earnings Have Been Accounted For Conservatively

Ipca Laboratories Limited (NSE:IPCALAB) Not Lagging Market On Growth Or Pricing

May 24
Ipca Laboratories Limited (NSE:IPCALAB) Not Lagging Market On Growth Or Pricing

Investors Interested In Ipca Laboratories Limited's (NSE:IPCALAB) Earnings

Feb 07
Investors Interested In Ipca Laboratories Limited's (NSE:IPCALAB) Earnings

Here's Why Ipca Laboratories (NSE:IPCALAB) Can Manage Its Debt Responsibly

Jan 09
Here's Why Ipca Laboratories (NSE:IPCALAB) Can Manage Its Debt Responsibly

Is Ipca Laboratories (NSE:IPCALAB) A Risky Investment?

Aug 20
Is Ipca Laboratories (NSE:IPCALAB) A Risky Investment?

Ipca Laboratories (NSE:IPCALAB) Has A Pretty Healthy Balance Sheet

Feb 28
Ipca Laboratories (NSE:IPCALAB) Has A Pretty Healthy Balance Sheet

Here's Why Ipca Laboratories (NSE:IPCALAB) Can Manage Its Debt Responsibly

Sep 20
Here's Why Ipca Laboratories (NSE:IPCALAB) Can Manage Its Debt Responsibly

Estimating The Intrinsic Value Of Ipca Laboratories Limited (NSE:IPCALAB)

Aug 31
Estimating The Intrinsic Value Of Ipca Laboratories Limited (NSE:IPCALAB)

Is Ipca Laboratories (NSE:IPCALAB) A Risky Investment?

Jun 22
Is Ipca Laboratories (NSE:IPCALAB) A Risky Investment?

Calculating The Fair Value Of Ipca Laboratories Limited (NSE:IPCALAB)

May 28
Calculating The Fair Value Of Ipca Laboratories Limited (NSE:IPCALAB)

Does Ipca Laboratories (NSE:IPCALAB) Have A Healthy Balance Sheet?

Mar 15
Does Ipca Laboratories (NSE:IPCALAB) Have A Healthy Balance Sheet?

These 4 Measures Indicate That Ipca Laboratories (NSE:IPCALAB) Is Using Debt Reasonably Well

Sep 20
These 4 Measures Indicate That Ipca Laboratories (NSE:IPCALAB) Is Using Debt Reasonably Well

Is Now The Time To Put Ipca Laboratories (NSE:IPCALAB) On Your Watchlist?

Aug 09
Is Now The Time To Put Ipca Laboratories (NSE:IPCALAB) On Your Watchlist?

Does Ipca Laboratories (NSE:IPCALAB) Have A Healthy Balance Sheet?

Jun 08
Does Ipca Laboratories (NSE:IPCALAB) Have A Healthy Balance Sheet?

How Does Ipca Laboratories Limited (NSE:IPCALAB) Stand Up To These Simple Dividend Safety Checks?

Mar 26
How Does Ipca Laboratories Limited (NSE:IPCALAB) Stand Up To These Simple Dividend Safety Checks?

Do Ipca Laboratories's (NSE:IPCALAB) Earnings Warrant Your Attention?

Mar 13
Do Ipca Laboratories's (NSE:IPCALAB) Earnings Warrant Your Attention?

Trade Alert: The Compliance Officer Of Ipca Laboratories Limited (NSE:IPCALAB), Harish Kamath, Has Sold Some Shares Recently

Feb 28
Trade Alert: The Compliance Officer Of Ipca Laboratories Limited (NSE:IPCALAB), Harish Kamath, Has Sold Some Shares Recently

Ipca Laboratories Limited's (NSE:IPCALAB) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Feb 23
Ipca Laboratories Limited's (NSE:IPCALAB) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Does Ipca Laboratories' (NSE:IPCALAB) CEO Salary Compare Well With Industry Peers?

Feb 11
Does Ipca Laboratories' (NSE:IPCALAB) CEO Salary Compare Well With Industry Peers?

Could The Ipca Laboratories Limited (NSE:IPCALAB) Ownership Structure Tell Us Something Useful?

Jan 30
Could The Ipca Laboratories Limited (NSE:IPCALAB) Ownership Structure Tell Us Something Useful?

The Ipca Laboratories (NSE:IPCALAB) Share Price Is Up 264% And Shareholders Are Boasting About It

Jan 15
The Ipca Laboratories (NSE:IPCALAB) Share Price Is Up 264% And Shareholders Are Boasting About It

CEO報酬分析

Ipca Laboratories の収益と比較して、Pranay Godha の報酬はどのように変化したか?
日付総報酬給与会社業績
Sep 30 2024n/an/a

₹7b

Jun 30 2024n/an/a

₹6b

Mar 31 2024₹65m₹17m

₹5b

Dec 31 2023n/an/a

₹6b

Sep 30 2023n/an/a

₹5b

Jun 30 2023n/an/a

₹5b

Mar 31 2023₹51m₹13m

₹5b

Dec 31 2022n/an/a

₹5b

Sep 30 2022n/an/a

₹6b

Jun 30 2022n/an/a

₹7b

Mar 31 2022₹46m₹12m

₹9b

Dec 31 2021n/an/a

₹9b

Sep 30 2021n/an/a

₹10b

Jun 30 2021n/an/a

₹10b

Mar 31 2021₹32m₹8m

₹11b

Dec 31 2020n/an/a

₹11b

Sep 30 2020n/an/a

₹10b

Jun 30 2020n/an/a

₹9b

Mar 31 2020₹33m₹8m

₹6b

Dec 31 2019n/an/a

₹6b

Sep 30 2019n/an/a

₹6b

Jun 30 2019n/an/a

₹5b

Mar 31 2019₹29m₹8m

₹4b

Mar 31 2018₹25m₹7m

₹2b

報酬と市場: Pranayの 総報酬 ($USD 772.50K ) は、 Indian市場 ($USD 590.37K ) の同規模の企業の平均を上回っています。

報酬と収益: Pranayの報酬は過去 1 年間で 20% 以上増加しました。


CEO(最高経営責任者

Pranay Godha (52 yo)

1.6yrs

在職期間

₹65,228,222

報酬

Mr. Pranay Premchand Godha served as the President of APIs & Generics at Ipca Laboratories Limited and joined it on April 16, 2003. He serves as Non-Executive, Non-Independent Director at Unichem Laborator...


取締役

名称ポジション在職期間報酬所有権
Premchand Godha
Executive Chairman49.1yrs₹123.00m2.29%
₹ 9.3b
Pranay Godha
CEO, MD & Executive Director16yrs₹65.23m0.67%
₹ 2.7b
Ajit Kumar Jain
CFO, MD & Executive Director30.3yrs₹84.44m0.017%
₹ 66.8m
Prashant Godha
Executive Director13.3yrs₹69.76m0.62%
₹ 2.5b
Narendra Mairpady
Additional Independent Director2.1yrs₹1.25mデータなし
Kamal Seth
Lead Independent Director5.7yrs₹1.60m0.00067%
₹ 2.7m
Swati Patankar
Independent Directorless than a year₹250.00kデータなし
Vivek Shiralkar
Independent Directorless than a yearデータなし0.000080%
₹ 323.0k

9.5yrs

平均在職期間

69yo

平均年齢

経験豊富なボード: IPCALABの 取締役会経験豊富 であると考えられます ( 9.5年の平均在任期間)。